Biomaterial Database

[Intravenous thrombolysis in the acute phase of myocardial infarct]. 1985

C de Fuster

UI	MeSH Term	Description	Entries
D007263	Infusions, Parenteral	The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.	Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D009203	Myocardial Infarction	NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).	Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003327	Coronary Disease	An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.	Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005343	Fibrinolytic Agents	Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.	Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208	Acute Disease	Disease having a short and relatively severe course.	Acute Diseases,Disease, Acute,Diseases, Acute

Related Publications

C de Fuster

[Intravenous thrombolysis in acute myocardial infarct].

January 1986, Zeitschrift fur Kardiologie,

C de Fuster

[Thrombolysis in acute myocardial infarct].

May 1994, Deutsche medizinische Wochenschrift (1946),

C de Fuster

[Thrombolysis in acute myocardial infarct].

June 1996, Der Internist,

C de Fuster

[Thrombolysis in acute myocardial infarct].

January 1986, Archivos del Instituto de Cardiologia de Mexico,

C de Fuster

[Thrombolysis in acute myocardial infarct].

February 1989, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,

C de Fuster

[Thrombolysis in acute myocardial infarct].

January 1995, Orvosi hetilap,

C de Fuster

[Thrombolysis in acute myocardial infarct].

August 1991, Therapeutische Umschau. Revue therapeutique,

C de Fuster

[Thrombolysis in acute myocardial infarct].

September 1994, Schweizerische medizinische Wochenschrift,

C de Fuster

[Clinical aspects of reperfusion arrhythmia following intravenous thrombolysis in acute myocardial infarct].

May 1987, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,